Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.8.0.1
Accrued Expenses
9 Months Ended
Sep. 30, 2017
Accrued Liabilities [Abstract]  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
4. Accrued Expenses
 
Accrued expenses consist of the following: 
 
 
 
September 30,
 
 
 
 
 
2017
 
December 31,
 
 
 
(unaudited)
 
2016
 
Clinical Trials
 
$
977,882
 
$
770,158
 
Payroll and Benefits
 
 
564,525
 
 
668,802
 
Professional Fees
 
 
163,703
 
 
174,342
 
Short-Term Portion of Capital Lease Obligation
 
 
12,645
 
 
12,645
 
Consulting
 
 
5,517
 
 
44,983
 
Total Accrued Expenses
 
$
1,724,272
 
$
1,670,930